Centene (CNC) Stock Forecast, Price Target & Predictions
CNC Stock Forecast
Centene stock forecast is as follows: an average price target of $92.60 (represents a 22.89% upside from CNC’s last price of $75.35) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
CNC Price Target
The average price target for Centene (CNC) is $92.60 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $112.00 to $72.00. This represents a potential 22.89% upside from CNC's last price of $75.35.
CNC Analyst Ratings
According to 14 Wall Street analysts, Centene's rating consensus is 'Buy'. The analyst rating breakdown for CNC stock is 0 'Strong Buy' (0.00%), 8 'Buy' (57.14%), 6 'Hold' (42.86%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Centene Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | David Windley | Jefferies | $72.00 | $71.00 | 1.41% | -4.45% |
| Sep 05, 2024 | Andrew Mok | Barclays | $97.00 | $73.26 | 32.41% | 28.73% |
| Jul 11, 2024 | David Windley | Jefferies | $83.00 | $66.38 | 25.04% | 10.15% |
| Apr 29, 2024 | David Windley | Jefferies | $90.00 | $73.83 | 21.90% | 19.44% |
| Apr 15, 2024 | Stephen Baxter | Wells Fargo | $93.00 | $73.02 | 27.36% | 23.42% |
| Feb 08, 2023 | - | Goldman Sachs | $74.00 | $72.56 | 1.98% | -1.79% |
| Feb 08, 2023 | - | J.P. Morgan | $94.00 | $70.98 | 32.43% | 24.75% |
| Feb 08, 2023 | - | Barclays | $93.00 | $70.98 | 31.02% | 23.42% |
| Jan 06, 2023 | - | J.P. Morgan | $98.00 | $78.66 | 24.59% | 30.06% |
| Aug 26, 2022 | Stephen Baxter | Wells Fargo | $99.00 | $95.73 | 3.42% | 31.39% |
The latest Centene stock forecast, released on Sep 10, 2024 by David Windley from Jefferies, set a price target of $72.00, which represents a 1.41% increase from the stock price at the time of the forecast ($71.00), and a -4.45% decrease from CNC last price ($75.35).
Centene Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 3 | 5 |
| Avg Price Target | $84.50 | $84.00 | $87.00 |
| Last Closing Price | $75.35 | $75.35 | $75.35 |
| Upside/Downside | 12.14% | 11.48% | 15.46% |
In the current month, the average price target of Centene stock is $84.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 12.14% increase as opposed to Centene's last price of $75.35. This month's average price target is up 0.60% compared to last quarter, and down -2.87% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 10, 2024 | Jefferies | Hold | Hold | Hold |
| Sep 05, 2024 | Barclays | Overweight | Overweight | Hold |
| Aug 22, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Aug 19, 2024 | Wells Fargo | Buy | Buy | Hold |
| Aug 05, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Jul 29, 2024 | Wells Fargo | Buy | Buy | Hold |
| Jul 24, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jul 24, 2024 | Jefferies | Buy | Hold | Downgrade |
| Jul 11, 2024 | Jefferies | Buy | Buy | Hold |
| Jun 21, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Centene's last stock rating was published by Jefferies on Sep 10, 2024. The company gave CNC a "Hold" rating, the same as its previous rate.
Centene Financial Forecast
Centene Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $39.46B | - | $37.61B | $38.89B | $35.56B | $35.87B | - | $37.19B | $32.57B | $32.41B | $31.02B | $29.98B | $28.29B | $29.09B | $27.71B | $26.02B | $18.86B | $18.98B |
| Avg Forecast | $42.96B | $41.24B | $41.48B | $42.55B | $40.05B | $39.30B | $40.20B | $40.59B | $38.28B | $38.03B | $36.83B | $36.43B | $36.14B | $36.24B | $36.56B | $36.14B | $35.40B | $35.50B | $35.56B | $34.52B | $32.50B | $31.62B | $30.19B | $29.49B | $28.32B | $28.25B | $27.47B | $24.55B | $18.45B | $18.46B |
| High Forecast | $44.31B | $42.54B | $42.79B | $43.89B | $41.31B | $40.54B | $41.47B | $41.87B | $39.49B | $38.32B | $37.99B | $37.58B | $37.20B | $37.31B | $37.71B | $37.27B | $36.51B | $36.62B | $35.56B | $35.61B | $33.52B | $32.62B | $31.14B | $30.42B | $29.22B | $29.14B | $28.34B | $25.33B | $19.03B | $19.04B |
| Low Forecast | $41.58B | $39.92B | $40.15B | $41.18B | $38.76B | $38.04B | $38.91B | $39.29B | $37.06B | $37.76B | $35.65B | $35.26B | $35.55B | $35.73B | $35.38B | $34.98B | $34.26B | $34.36B | $35.56B | $32.80B | $30.88B | $30.04B | $28.69B | $28.02B | $26.91B | $26.84B | $26.10B | $23.33B | $17.53B | $17.54B |
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 12 | 11 | 9 | 10 | 16 | 9 | 10 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | - | 1.03% | 1.08% | 1.00% | 1.01% | - | 1.08% | 1.00% | 1.02% | 1.03% | 1.02% | 1.00% | 1.03% | 1.01% | 1.06% | 1.02% | 1.03% |
Centene's average Quarter revenue forecast for Mar 24 based on 3 analysts is $36.43B, with a low forecast of $35.26B, and a high forecast of $37.58B. CNC's average Quarter revenue forecast represents a -7.67% decrease compared to the company's last Quarter revenue of $39.46B (Dec 23).
Centene EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 12 | 11 | 9 | 10 | 16 | 9 | 10 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-194.00M | - | $1.17B | $1.58B | $649.00M | $1.16B | - | $1.64B | $1.24B | $1.27B | $-23.00M | $1.47B | $453.00M | $1.26B | $2.46B | $599.00M | $548.00M | $435.00M |
| Avg Forecast | $1.45B | $1.39B | $1.40B | $1.43B | $1.35B | $1.32B | $1.35B | $1.37B | $1.29B | $1.28B | $1.24B | $1.87B | $1.22B | $1.22B | $1.23B | $1.70B | $1.19B | $1.43B | $1.20B | $1.54B | $1.20B | $1.30B | $-25.61M | $1.44B | $462.64M | $881.20M | $2.44B | $677.66M | $548.00M | $430.42M |
| High Forecast | $1.49B | $1.43B | $1.44B | $1.48B | $1.39B | $1.37B | $1.40B | $1.41B | $1.33B | $1.29B | $1.28B | $2.24B | $1.25B | $1.26B | $1.27B | $2.04B | $1.23B | $1.72B | $1.20B | $1.85B | $1.44B | $1.56B | $-20.49M | $1.72B | $555.17M | $1.06B | $2.93B | $813.19M | $657.60M | $516.51M |
| Low Forecast | $1.40B | $1.34B | $1.35B | $1.39B | $1.31B | $1.28B | $1.31B | $1.32B | $1.25B | $1.27B | $1.20B | $1.49B | $1.20B | $1.20B | $1.19B | $1.36B | $1.15B | $1.15B | $1.20B | $1.23B | $961.63M | $1.04B | $-30.73M | $1.15B | $370.11M | $704.96M | $1.96B | $542.13M | $438.40M | $344.34M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.16% | - | 0.95% | 0.93% | 0.54% | 0.81% | - | 1.06% | 1.03% | 0.98% | 0.90% | 1.03% | 0.98% | 1.43% | 1.01% | 0.88% | 1.00% | 1.01% |
13 analysts predict CNC's average Quarter EBITDA for Sep 23 to be $1.22B, with a high of $1.26B and a low of $1.20B. This is 4.22% upper than Centene's previous annual EBITDA (Jun 23) of $1.17B.
Centene Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 12 | 11 | 9 | 10 | 16 | 9 | 10 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $45.00M | - | $1.06B | $1.13B | $-219.00M | $738.00M | - | $849.00M | $593.00M | $584.00M | $-535.00M | $699.00M | $-12.00M | $568.00M | $1.21B | $46.00M | $209.00M | $95.00M |
| Avg Forecast | $547.79M | $1.08B | $1.37B | $1.36B | $524.35M | $994.61M | $1.09B | $1.25B | $357.70M | $779.28M | $1.12B | $935.57M | $222.93M | $822.63M | $1.09B | $850.52M | $434.01M | $657.34M | $860.42M | $773.20M | $580.66M | $597.58M | $-595.71M | $681.42M | $-12.26M | $398.19M | $1.20B | $52.04M | $209.00M | $94.00M |
| High Forecast | $570.20M | $1.12B | $1.43B | $1.42B | $545.80M | $1.04B | $1.14B | $1.30B | $372.34M | $880.00M | $1.17B | $1.12B | $274.78M | $943.15M | $1.13B | $1.02B | $451.77M | $788.81M | $860.42M | $927.84M | $696.80M | $717.10M | $-476.57M | $817.70M | $-9.80M | $477.82M | $1.44B | $62.45M | $250.80M | $112.80M |
| Low Forecast | $524.95M | $1.04B | $1.32B | $1.31B | $502.49M | $953.16M | $1.05B | $1.20B | $342.79M | $705.06M | $1.08B | $748.45M | $197.01M | $660.20M | $1.04B | $680.41M | $415.92M | $525.87M | $860.42M | $618.56M | $464.53M | $478.07M | $-714.85M | $545.13M | $-14.71M | $318.55M | $956.69M | $41.63M | $167.20M | $75.20M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | - | 0.97% | 1.33% | -0.50% | 1.12% | - | 1.10% | 1.02% | 0.98% | 0.90% | 1.03% | 0.98% | 1.43% | 1.01% | 0.88% | 1.00% | 1.01% |
Centene's average Quarter net income forecast for Mar 24 is $935.57M, with a range of $748.45M to $1.12B. CNC's average Quarter net income forecast represents a 1979.04% increase compared to the company's last Quarter net income of $45.00M (Dec 23).
Centene SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 12 | 11 | 9 | 10 | 16 | 9 | 10 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $3.49B | - | $3.02B | $3.01B | $3.20B | $2.85B | - | $2.75B | $2.84B | $2.68B | $2.27B | $2.37B | $3.10B | $2.88B | $2.63B | $2.73B | $1.73B | $1.62B |
| Avg Forecast | $3.71B | $3.56B | $3.58B | $3.68B | $3.46B | $3.40B | $3.47B | $3.51B | $3.31B | $3.29B | $3.18B | $3.02B | $3.12B | $3.13B | $3.16B | $2.75B | $3.06B | $3.02B | $3.07B | $2.50B | $2.75B | $2.75B | $2.53B | $2.31B | $3.16B | $2.02B | $2.61B | $3.28B | $1.80B | $1.66B |
| High Forecast | $3.83B | $3.68B | $3.70B | $3.79B | $3.57B | $3.50B | $3.58B | $3.62B | $3.41B | $3.31B | $3.28B | $3.63B | $3.21B | $3.22B | $3.26B | $3.30B | $3.15B | $3.63B | $3.07B | $3.00B | $3.31B | $3.30B | $3.04B | $2.77B | $3.80B | $2.43B | $3.13B | $3.93B | $2.16B | $2.00B |
| Low Forecast | $3.59B | $3.45B | $3.47B | $3.56B | $3.35B | $3.29B | $3.36B | $3.39B | $3.20B | $3.26B | $3.08B | $2.42B | $3.07B | $3.09B | $3.06B | $2.20B | $2.96B | $2.42B | $3.07B | $2.00B | $2.20B | $2.20B | $2.02B | $1.85B | $2.53B | $1.62B | $2.09B | $2.62B | $1.44B | $1.33B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.12% | - | 0.95% | 1.09% | 1.05% | 0.94% | - | 1.10% | 1.03% | 0.98% | 0.90% | 1.03% | 0.98% | 1.43% | 1.01% | 0.83% | 0.96% | 0.97% |
Centene's average Quarter SG&A projection for Mar 24 is $3.02B, based on 3 Wall Street analysts, with a range of $2.42B to $3.63B. The forecast indicates a -13.28% fall compared to CNC last annual SG&A of $3.49B (Dec 23).
Centene EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 5 | 6 | 12 | 11 | 9 | 10 | 16 | 9 | 10 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.08 | - | - | $2.05 | $-0.39 | $1.29 | - | $1.46 | $1.02 | $1.00 | $-0.92 | $1.20 | $-0.02 | $0.98 | $2.08 | $0.08 | $0.50 | $0.23 |
| Avg Forecast | $1.03 | $2.04 | $2.59 | $2.57 | $0.99 | $1.87 | $2.06 | $2.36 | $0.67 | $1.47 | $2.12 | $2.06 | $0.42 | $1.55 | $2.05 | $2.00 | $0.82 | $1.23 | $1.60 | $1.68 | $0.98 | $1.24 | $1.21 | $1.50 | $0.47 | $0.96 | $2.38 | $0.98 | $0.73 | $0.95 |
| High Forecast | $1.07 | $2.12 | $2.69 | $2.67 | $1.03 | $1.95 | $2.14 | $2.46 | $0.70 | $1.66 | $2.20 | $2.15 | $0.52 | $1.78 | $2.14 | $2.08 | $0.85 | $1.28 | $1.60 | $1.75 | $1.02 | $1.29 | $1.26 | $1.56 | $0.49 | $1.00 | $2.48 | $1.02 | $0.76 | $0.99 |
| Low Forecast | $0.99 | $1.95 | $2.48 | $2.46 | $0.95 | $1.80 | $1.97 | $2.26 | $0.65 | $1.33 | $2.03 | $1.98 | $0.37 | $1.24 | $1.97 | $1.92 | $0.78 | $1.18 | $1.60 | $1.58 | $0.91 | $1.16 | $1.13 | $1.40 | $0.44 | $0.90 | $2.23 | $0.92 | $0.68 | $0.89 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | - | 0.00% | 1.02% | -0.48% | 1.05% | - | 0.87% | 1.04% | 0.80% | -0.76% | 0.80% | -0.04% | 1.02% | 0.87% | 0.08% | 0.68% | 0.24% |
According to 3 Wall Street analysts, Centene's projected average Quarter EPS for Mar 24 is $2.06, with a low estimate of $1.98 and a high estimate of $2.15. This represents a 2351.18% increase compared to CNC previous annual EPS of $0.08 (Dec 23).
Centene Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BHG | NeueHealth | $16.35 | $7.68K | 46872.48% | Hold |
| CVS | CVS Health | $57.98 | $103.77 | 78.98% | Hold |
| HUM | Humana | $321.56 | $500.84 | 55.75% | Hold |
| CNC | Centene | $75.35 | $92.60 | 22.89% | Buy |
| ELV | Elevance Health | $550.84 | $556.91 | 1.10% | Buy |
| MOH | Molina Healthcare | $358.20 | $358.63 | 0.12% | Hold |
| UNH | UnitedHealth Group | $594.32 | $569.20 | -4.23% | Buy |
| OSCR | Oscar Health | $21.61 | $20.20 | -6.52% | Buy |
| CI | Cigna | $364.72 | $318.74 | -12.61% | Buy |
| ALHC | Alignment Healthcare | $11.89 | $9.50 | -20.10% | Buy |
CNC Forecast FAQ
Is Centene a good buy?
Yes, according to 14 Wall Street analysts, Centene (CNC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 57.14% of CNC's total ratings.
What is CNC's price target?
Centene (CNC) average price target is $92.6 with a range of $72 to $112, implying a 22.89% from its last price of $75.35. The data is based on 14 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Centene stock go up soon?
According to Wall Street analysts' prediction for CNC stock, the company can go up by 22.89% (from the last price of $75.35 to the average price target of $92.6), up by 48.64% based on the highest stock price target, and down by -4.45% based on the lowest stock price target.
Can Centene stock reach $110?
CNC's highest twelve months analyst stock price target of $112 supports the claim that Centene can reach $110 in the near future.
What is Centene's current price target trend?
2 Wall Street analysts forecast a $84.5 price target for Centene (CNC) this month, up 12.14% from its last price of $75.35. Compared to the last 3 and 12 months, the average price target increased by 11.48% and increased by 15.46%, respectively.
What are Centene's analysts' financial forecasts?
Centene's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $160.14B (high $165.18B, low $155.01B), average EBITDA is $5.39B (high $5.56B, low $5.22B), average net income is $3.86B (high $4.02B, low $3.7B), average SG&A $13.84B (high $14.27B, low $13.39B), and average EPS is $7.28 (high $7.58, low $6.98). CNC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $168.23B (high $173.53B, low $162.84B), average EBITDA is $5.66B (high $5.84B, low $5.48B), average net income is $4.36B (high $4.54B, low $4.18B), average SG&A $14.54B (high $14.99B, low $14.07B), and average EPS is $8.22 (high $8.56, low $7.88).
Did the CNC's actual financial results beat the analysts' financial forecasts?
Based on Centene's last annual report (Dec 2023), the company's revenue was $154B, beating the average analysts forecast of $145.08B by 6.15%. Apple's EBITDA was $2.93B, missing the average prediction of $5.37B by -45.40%. The company's net income was $2.7B, missing the average estimation of $2.99B by -9.48%. Apple's SG&A was $12.56B, beating the average forecast of $12.16B by 3.28%. Lastly, the company's EPS was $4.97, missing the average prediction of $6.02 by -17.47%. In terms of the last quarterly report (Dec 2023), Centene's revenue was $39.46B, beating the average analysts' forecast of $36.14B by 9.17%. The company's EBITDA was $-194M, missing the average prediction of $1.22B by -115.94%. Centene's net income was $45M, missing the average estimation of $222.93M by -79.81%. The company's SG&A was $3.49B, beating the average forecast of $3.12B by 11.68%. Lastly, the company's EPS was $0.0842, missing the average prediction of $0.42 by -79.95%